Amedisys Stock Target Price and Analyst Consensus

AMED Stock  USD 93.61  0.08  0.09%   
The current analyst and expert consensus on Amedisys is Buy with 7 hold recommendations. The current projected Amedisys target price consensus is 96.1 with 11 analyst opinions. One of the most common ways Amedisys analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Amedisys vendors, executives, and/or customers. Amedisys recommendation module provides expert sentiment on the projected Amedisys target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on Amedisys to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
Lowest Forecast
Highest Forecast
Target Price
As of February 22, 2024, Gross Profit is expected to decline to about 993.6 M. In addition to that, Profit Margin is expected to decline to 0.05. At present, Amedisys' Total Debt is projected to increase significantly based on the last few years of reporting. The current year's Debt Current is expected to grow to about 60.8 M, whereas Accounts Payable is forecasted to decline to about 33 M.
It's important to approach Amedisys' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Amedisys Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Amedisys target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Amedisys' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   11  Buy
Most Amedisys analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Amedisys stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Amedisys, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Amedisys Target Price Projection

Amedisys' current and average target prices are 93.61 and 96.10, respectively. The current price of Amedisys is the price at which Amedisys is currently trading. On the other hand, Amedisys' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Amedisys Market Quote on 22nd of February 2024

Low Price93.25Odds
High Price93.75Odds


Target Price

Analyst Consensus On Amedisys Target Price

Low Estimate87.45Odds
High Estimate106.67Odds


Historical Lowest Forecast  87.45 Target Price  96.1 Highest Forecast  106.67
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Amedisys and the information provided on this page.

Amedisys Analyst Ratings

Amedisys' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Amedisys stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Amedisys' financials, market performance, and future outlook by experienced professionals. Amedisys' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Amedisys price targets

Amedisys' stock target price is an estimate of its future price, usually made by analysts. Using Amedisys' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Amedisys' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Amedisys' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Amedisys Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Amedisys is a key component of Amedisys valuation and have some predictive power on the future returns of a Amedisys.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Amedisys' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Amedisys in the context of predictive analytics.
Estimates (0)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Amedisys. Your research has to be compared to or analyzed against Amedisys' peers to derive any actionable benefits. When done correctly, Amedisys' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Amedisys.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Cash Cows Idea
Cash Cows
Invested over 20 shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 200 shares
Momentum Idea
Invested over 70 shares
When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:
Check out Macroaxis Advice on Amedisys to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Amedisys Stock analysis

When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
The data published in Amedisys' official financial statements usually reflect Amedisys' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Amedisys. For example, before you start analyzing numbers published by Amedisys accountants, it's critical to develop an understanding of what Amedisys' liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of Amedisys' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amedisys' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Amedisys' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Amedisys. Please utilize our Beneish M Score to check the likelihood of Amedisys' management manipulating its earnings.